11 Aug 2021 11:35
Ap24
Â
FORMÂ 38.5(a)
Â
IRISHÂ TAKEOVERÂ PANEL
Â
DISCLOSURE UNDER RULE 38.5(a) OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013
Â
DEALINGSÂ BYÂ CONNECTEDÂ EXEMPTÂ PRINCIPALÂ TRADERSÂ WITHÂ RECOGNISEDÂ INTERMEDIARYÂ STATUSÂ ANDÂ DEALINGÂ INÂ ACLIENT-SERVINGÂ CAPACITY
Â
1. KEYÂ INFORMATION
Â
Name of exempt principal trader | J.P. Morgan Securities Plc |
Company dealt in | UDG Healthcare Plc |
Class of relevant security to which the dealings being disclosed relate (Note 1) | €0.05 ordinary shares |
Date of dealing | 10 August 2021 |
Â
2. DEALINGS (Note 2)
Â
(a) Purchases and sales
Â
Total number of relevant securities acquired | Highest price paid (Note 3) | Lowest price paid (Note 3) |
103,373 | 10.7900 GBP | 10.7769 GBP |
Â
Â
Total number of securities disposed | Highest price received (Note 3) | Lowest price received (Note 3) |
61,583 | 10.7900 GBP | 10.7750 GBP |
Â
Â
(b) Derivatives transactions (other than options transactions)
Â
Product name, e.g. CFD | Nature of transaction (Note 4) | Number of relevant securities (Note 5) | Price per unit (Note 3) |
Equity Swap | Decrease Long   Decrease Short      Increase Long    Increase Short   | 4,378 18  696 1,392 428 21,159 17,657  3,091 880 493  65,946 7,079 800 | 10.7803 GBP 10.7900 GBP  10.7798 GBP 10.7800 GBP 10.7836 GBP 10.7898 GBP 10.7900 GBP  10.7798 GBP 10.7895 GBP 10.7898 GBP  10.7804 GBP 10.7809 GBP 10.7902 GBP |
Â
Ap25
Â
(c) Options transactions in respect of existing relevant securities
Â
Â
(i) Writing, selling, purchasing or varying
Â
Product name, e.g. call option | Writing, selling, purchasing, varying etc. | Number of securities to which the option relates (Note 5) | Exercise price | Type, e.g. American, European etc. | Expiry date | Option money paid/received per unit (Note 3) |
 |  |  |  |  |  |  |
Â
Â
(ii) Exercising
Â
Product name, e.g. call option | Number of securities | Exercise price per unit (Note 3) |
 |  |  |
Â
Â
3. Â OTHERÂ INFORMATION
Â
Agreements, arrangements or understandings relating to options or derivatives
Â
Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securitiesunder any option referred to on this form or relating to the voting rights or future acquisitionor disposal of any relevant securities to which any derivative referred to on this form is referenced.If none, this should be stated.Â
Â
Â
Â
Â
Date of disclosure | 11 August 2021 |
Contact name | Alwyn Basch |
Telephone number | 020 7742 7407 |
Name of offeree/offeror with which connected | UDG Healthcare Plc |
Nature of connection (Note 6) | Financial adviser to CD&R Fund XI |
Â
Â
Â
Â
Follow the stocks